Orissa International completed a comprehensive market research project for an American life science specialist seeking to understand opportunities in Singapore and Indonesia, with a particular focus on biosafety, biosecurity, and the pharmaceutical and biotechnology segments. The study provided an in-depth analysis of key developments in biorisk management programs, including training and facility operations. It also examined infrastructure trends such as laboratory design, commissioning, and performance optimization, with insights into funding sources from government, private sector, and international bodies.
The research highlighted recent investments in high-containment laboratories, workforce training initiatives, and the government’s strategic focus on pandemic preparedness and biopharmaceutical R&D. We identified leading market players, including research and national laboratories, and profiled potential partners with strong industry connections. The report also outlined key associations supporting the sector and offered strategic recommendations, including market entry considerations and taxation implications.